DEXTENZA (J1096) has coverage and separate payment for 100% of fee-for-service Medicare patients in the ASC setting.

As of January 1, 2023, DEXTENZA has separate payment in the ASC* setting due to meeting the criteria set forth in the non-opioid as a surgical supply provision by CMS.

Select your state from the dropdown menu below to find regional Medicare Advantage and Commercial coverage for DEXTENZA.

COMMERCIAL ASSURANCE PROGRAM

The DEXTENZA Commercial Assurance Program (CAP) is a patient assistance program designed to assist eligible patients, who have coverage for DEXTENZA (J1096) through a commercial insurance plan.§